emtricitabine/rilpivirine/tenofovir DF (FTC/RPV/TDF, TAF/FTC/RPV, Complera, Odefsey)
Jump to navigation
Jump to search
Indications
- treatment-naive HIV-infected patients
Dosage
- once daily dosing
Odefsey: (smallest pill of any single tablet)[3]
- emtricitabine 200 mg
- rilpivirine 25 mg
- tenofovir alafenamide (TAF; 25 mg)
Storage
- store in orginal container
- must be protected from moisture
- original container has a desiccant[2]
More general terms
Components
References
- ↑ FDA: August 10, 2011 Approval of Complera: emtricitabine/rilpivirine/tenofovir DF fixed dose combination http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm267592.htm
- ↑ 2.0 2.1 Prescriber's Letter 21(6): 2014 Oral Meds to Keep in Original Containers Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=300622&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 3.0 3.1 Brooks M Medscape. March 2, 2016 FDA Clears Gilead's Second TAF-Based HIV Regimen (Odefsey) http://www.medscape.com/viewarticle/859730